An immuno-based treatment targeting cancer cells with mismatch repair-deficiency could help those with the disease treat ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...

A Stage 4 cancer survivor is grateful for a 'lifesaving' clinical trial, but experts are wary over potential federal funding ...

TNX-1700 is in preclinical development for gastric and colorectal cancers ...

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...

HonorHealth Research Institute's new downtown Phoenix laboratory has produced its first study, centered on a promising new ...